Showing results (181-190 of 201) with videos related to
Sort By:
Pageof 21
Scandinavian Journal of Urology and Nephrology|November 26, 1999
Prostate cancer registration in four Swedish regions 1996-- differences in incidence, age structure and managementG Sandblom, E Mattsson, J Nilsson, et al.Urology|April 1, 1997
Planning controlled clinical trials. Prostatic cancerL Denis, B J Norlén, L Holmberg, et al.Cancer Letters|March 19, 1997
Soy and rye diets inhibit the development of Dunning R3327 prostatic adenocarcinoma in ratsJ X Zhang, G Hallmans, M Landström, et al.Acta Radiologica (Stockholm, Sweden : 1987)|March 31, 2000
Quantitative bone scintigraphy. A methodological evaluation in prostate cancerA Rydh, K R Ahlström, A Larsson, et al.Scandinavian Journal of Urology and Nephrology|August 31, 2002
Effects of finasteride on vascular endothelial growth factorS Häggström, N Tørring, K Møller, et al.Urology|February 1, 2003
Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3A Widmark, S D Fosså, P Lundmo, et al.Prostate Cancer and Prostatic Diseases|October 1, 2008
Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasiaJ Hammarsten, J-E Damber, M Karlsson, et al.Maturitas|December 1, 1981
Effects of sex hormone binding globulin capacity and pregnancy zone protein of treatment with combinations of ethinyl-oestradiol and norethisteroneU B Ottosson, J E Damber, M G Damber, et al.Scandinavian Journal of Urology and Nephrology. Supplementum|January 6, 2001
Cellular and molecular pathology of prostate cancer precursorsC S Foster, D G Bostwick, H Bonkhoff, et al.Scandinavian Journal of Urology and Nephrology|May 25, 2002
Prostate-specific antigen as surrogate for characterizing prostate cancer subgroupsG Sandblom, L Holmberg, J-E Damber, et al.Pageof 21